{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:01:56Z","timestamp":1792425716010,"version":"4.5.0"},"reference-count":126,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.coviro.2020.08.006","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T05:33:15Z","timestamp":1600925595000},"page":"59-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"special_numbering":"C","title":["Protective and enhancing interactions among dengue viruses 1-4 and Zika virus"],"prefix":"10.1016","volume":"43","author":[{"given":"Leah C","family":"Katzelnick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5036-0336","authenticated-orcid":false,"given":"Sandra","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2020.08.006_bib0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.antiviral.2016.03.010","article-title":"Zika virus: history, emergence, biology, and prospects for control","volume":"130","author":"Weaver","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.08.006_bib0010","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1128\/MMBR.00009-15","article-title":"Dengue hemorrhagic fever at 60 years: early evolution of concepts of causation and treatment","volume":"79","author":"Halstead","year":"2015","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.coviro.2020.08.006_bib0015","series-title":"Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control","author":"World Health Organization","year":"2009"},{"key":"10.1016\/j.coviro.2020.08.006_bib0020","series-title":"Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention, and Control","author":"World Health Organization","year":"1997"},{"key":"10.1016\/j.coviro.2020.08.006_bib0025","doi-asserted-by":"crossref","first-page":"S891","DOI":"10.1093\/infdis\/jix448","article-title":"Zika virus infection in pregnancy: maternal, fetal, and neonatal considerations","volume":"216","author":"Zorrilla","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2020.08.006_bib0030","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","article-title":"Guillain-Barr\u00e9 syndrome outbreak associated with Zika virus infection in French polynesia: a case-control study","volume":"387","author":"Cao-Lormeau","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2020.08.006_bib0035","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taz077","article-title":"Dengue, Zika and chikungunya during pregnancy: pre- and post-travel advice and clinical management","volume":"26","author":"Vouga","year":"2019","journal-title":"J Travel Med"},{"key":"10.1016\/j.coviro.2020.08.006_bib0040","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2020.08.006_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.15272","article-title":"Mapping global environmental suitability for Zika virus","volume":"5","author":"Messina","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.coviro.2020.08.006_bib0050","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taz012","article-title":"Zika in Angola and India","volume":"26","author":"Hamer","year":"2019","journal-title":"J Travel Med"},{"key":"10.1016\/j.coviro.2020.08.006_bib0055","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taz062","article-title":"Severe dengue in travellers: pathogenesis, risk and clinical management","volume":"26","author":"Halstead","year":"2019","journal-title":"J Travel Med"},{"key":"10.1016\/j.coviro.2020.08.006_bib0060","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/tay044","article-title":"Zika in travellers 1947\u20132017: a systematic review","volume":"25","author":"Wilder-Smith","year":"2018","journal-title":"J Travel Med"},{"key":"10.1016\/j.coviro.2020.08.006_bib0065","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taz072","article-title":"Imported dengue in Spain: a nationwide analysis with predictive time series analyses","volume":"26","author":"Redondo-Bravo","year":"2019","journal-title":"J Travel Med"},{"key":"10.1016\/j.coviro.2020.08.006_bib0070","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","article-title":"Structure of dengue virus: implications for flavivirus organization, maturation, and fusion","volume":"108","author":"Kuhn","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2020.08.006_bib0075","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0065-3527(03)59005-4","article-title":"Antigenic structure of flavivirus proteins","volume":"59","author":"Roehrig","year":"2003","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.coviro.2020.08.006_bib0080","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1126\/science.1185181","article-title":"Cross-reacting antibodies enhance dengue virus infection in humans","volume":"328","author":"Dejnirattisai","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.coviro.2020.08.006_bib0085","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01559-15","article-title":"Genotypic differences in dengue virus neutralization are explained by a single amino acid mutation that modulates virus breathing","volume":"6","author":"Dowd","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.coviro.2020.08.006_bib0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002930","article-title":"Structural basis of differential neutralization of DENV-1 genotypes by an antibody that recognizes a cryptic epitope","volume":"8","author":"Austin","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2020.08.006_bib0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004386","article-title":"Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera","volume":"10","author":"de Alwis","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2020.08.006_bib0100","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0022-3476(66)80249-4","article-title":"Shock associated with dengue infection","volume":"68","author":"Cohen","year":"1966","journal-title":"J Pediatr"},{"key":"10.1016\/j.coviro.2020.08.006_bib0105","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.aan6836","article-title":"Antibody-dependent enhancement of severe dengue disease in humans","volume":"358","author":"Katzelnick","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.coviro.2020.08.006_bib0110","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41586-018-0157-4","article-title":"Reconstruction of antibody dynamics and infection histories to evaluate dengue risk","volume":"557","author":"Salje","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2020.08.006_sbref0115","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1126\/science.abb6143","article-title":"Zika virus infection enhances future risk of severe dengue disease","volume":"369","author":"Katzelnick","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.coviro.2020.08.006_bib0120","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/978-981-10-8727-1_5","article-title":"The molecular specificity of the human antibody response to dengue virus infections","volume":"1062","author":"Gallichotte","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.coviro.2020.08.006_bib0125","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.1073\/pnas.1200566109","article-title":"Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions","volume":"109","author":"de Alwis","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2020.08.006_bib0130","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.chom.2020.04.007","article-title":"Identification of dengue virus serotype 3 specific antigenic sites targeted by neutralizing human antibodies","volume":"27","author":"Young","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2020.08.006_bib0135","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.12688\/f1000research.19197.1","article-title":"Recent advances in understanding dengue","volume":"8","author":"Halstead","year":"2019","journal-title":"F1000Research"},{"key":"10.1016\/j.coviro.2020.08.006_bib0140","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0065-3527(03)60011-4","article-title":"Neutralization and antibody-dependent enhancement of dengue viruses","volume":"60","author":"Halstead","year":"2003","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.coviro.2020.08.006_sbref0145","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1093\/infdis\/jiz618","article-title":"Antibody-dependent enhancement of severe disease is mediated by serum viral load in pediatric dengue virus infections","volume":"221","author":"Waggoner","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2020.08.006_bib0150","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-virology-101416-041848","article-title":"The good, the bad, and the shocking: the multiple roles of dengue virus nonstructural protein 1 in protection and pathogenesis","volume":"5","author":"Glasner","year":"2018","journal-title":"Annu Rev Virol"},{"key":"10.1016\/j.coviro.2020.08.006_bib0155","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1099\/jgv.0.000637","article-title":"Markers of dengue severity: a systematic review of cytokines and chemokines","volume":"97","author":"Lee","year":"2016","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2020.08.006_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-020-1496-1","article-title":"C-reactive protein as a potential biomarker for disease progression in dengue: a multi-country observational study","volume":"18","author":"Vuong","year":"2020","journal-title":"BMC Med"},{"key":"10.1016\/j.coviro.2020.08.006_bib0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003230","article-title":"Dengue virus neutralizing antibody levels associated with protection from infection in Thai cluster studies","volume":"8","author":"Buddhari","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.coviro.2020.08.006_bib0170","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1073\/pnas.1522136113","article-title":"Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort","volume":"113","author":"Katzelnick","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2020.08.006_bib0175","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/infdis\/jit273","article-title":"Reduced risk of disease during postsecondary dengue virus infections","volume":"208","author":"Olkowski","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2020.08.006_bib0180","doi-asserted-by":"crossref","first-page":"910","DOI":"10.4269\/ajtmh.2007.77.910","article-title":"Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences","volume":"77","author":"Gibbons","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.coviro.2020.08.006_bib0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002357","article-title":"Symptomatic versus inapparent outcome in repeat dengue virus infections is influenced by the time interval between infections and study year","volume":"7","author":"Montoya","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.coviro.2020.08.006_bib0190","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00873-13","article-title":"The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein","volume":"4","author":"Smith","year":"2013","journal-title":"mBio"},{"key":"10.1016\/j.coviro.2020.08.006_bib0195","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature14130","article-title":"Recognition determinants of broadly neutralizing human antibodies against dengue viruses","volume":"520","author":"Rouvinski","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2020.08.006_bib0200","doi-asserted-by":"crossref","first-page":"12562","DOI":"10.1128\/JVI.00871-13","article-title":"High-avidity and potently neutralizing cross-reactive human monoclonal antibodies derived from secondary dengue virus infection","volume":"87","author":"Tsai","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.08.006_bib0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005926","article-title":"Immune status alters the probability of apparent illness due to dengue virus infection: evidence from a pooled analysis across multiple cohort and cluster studies","volume":"11","author":"Clapham","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.coviro.2020.08.006_bib0210","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.4269\/ajtmh.15-0337","article-title":"Forty years of dengue surveillance at a tertiary pediatric hospital in Bangkok, Thailand, 1973\u20132012","volume":"94","author":"Nisalak","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.coviro.2020.08.006_bib0215","doi-asserted-by":"crossref","first-page":"449","DOI":"10.4269\/ajtmh.2006.74.449","article-title":"Serotype-specific differences in clinical manifestations of dengue","volume":"74","author":"Balmaseda","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.coviro.2020.08.006_bib0220","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/oxfordjournals.aje.a113932","article-title":"Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak","volume":"120","author":"Sangkawibha","year":"1984","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.coviro.2020.08.006_bib0225","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/aje\/152.9.793","article-title":"Epidemiologic studies on dengue in Santiago de Cuba, 1997","volume":"152","author":"Guzm\u00e1n","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.coviro.2020.08.006_bib0230","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003084","article-title":"Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity","volume":"3","author":"OhAinle","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coviro.2020.08.006_bib0235","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.3201\/eid1508.081500","article-title":"Dengue 1 virus and dengue hemorrhagic fever, French polynesia, 2001","volume":"15","author":"Hubert","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.coviro.2020.08.006_bib0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-45816-6","article-title":"Cross-serotype interactions and disease outcome prediction of dengue infections in Vietnam","volume":"9","author":"Aguas","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.coviro.2020.08.006_bib0245","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1086\/382280","article-title":"Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand","volume":"189","author":"Endy","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2020.08.006_bib0250","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/infdis\/jix609","article-title":"Neutralizing antibody correlates analysis of tetravalent dengue vaccine efficacy trials in Asia and Latin America","volume":"217","author":"Moodie","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2020.08.006_bib0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mBio.01123-16","article-title":"Dengue virus envelope dimer epitope monoclonal antibodies isolated from dengue patients are protective against Zika virus","volume":"7","author":"Swanstrom","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.coviro.2020.08.006_bib0260","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3201\/eid2305.161630","article-title":"Lack of durable cross-neutralizing antibodies against Zika virus from dengue virus infection","volume":"23","author":"Collins","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.coviro.2020.08.006_bib0265","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/infdis\/jiy164","article-title":"Longitudinal analysis of antibody cross-neutralization following Zika virus and dengue virus infection in Asia and the Americas","volume":"218","author":"Montoya","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2020.08.006_bib0270","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/infdis\/jiaa120","article-title":"Primary and secondary dengue virus infections elicit similar memory B-cell responses, but breadth to other serotypes and cross-reactivity to Zika Virus is higher in secondary dengue","volume":"222","author":"Andrade","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2020.08.006_bib0275","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nature18938","article-title":"Structural basis of potent Zika-dengue virus antibody cross-neutralization","volume":"536","author":"Barba-Spaeth","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2020.08.006_bib0280","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/s41591-018-0056-0","article-title":"Therapeutic and protective efficacy of a dengue antibody against Zika infection in rhesus monkeys","volume":"24","author":"Abbink","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2020.08.006_bib0285","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92428","article-title":"Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infections","volume":"2","author":"Kam","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.coviro.2020.08.006_sbref0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107584","article-title":"A human antibody neutralizes different flaviviruses by using different mechanisms","volume":"31","author":"Zhang","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.coviro.2020.08.006_bib0295","first-page":"1","article-title":"Dengue immune sera enhance Zika virus infection in human peripheral blood monocytes through Fc gamma receptors","volume":"13","author":"Li","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2020.08.006_bib0300","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/ni.3515","article-title":"Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with Zika virus","volume":"17","author":"Dejnirattisai","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coviro.2020.08.006_bib0305","doi-asserted-by":"crossref","first-page":"7852","DOI":"10.1073\/pnas.1607931113","article-title":"Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus","volume":"113","author":"Priyamvada","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2020.08.006_bib0310","first-page":"781","article-title":"Dengue virus-specific antibodies enhance Brazilian Zika virus infection","volume":"215","author":"Castanha","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2020.08.006_bib0315","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1126\/science.aal4365","article-title":"Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity","volume":"356","author":"Bardina","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.coviro.2020.08.006_bib0320","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1099\/jgv.0.000833","article-title":"A relevant in vitro human model for the study of Zika virus antibody-dependent enhancement","volume":"98","author":"Londono-Renteria","year":"2017","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2020.08.006_bib0325","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.chom.2018.10.008","article-title":"Cross-reactive dengue virus antibodies augment Zika virus infection of human placental macrophages","volume":"24","author":"Zimmerman","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2020.08.006_bib0330","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41426-018-0199-6","article-title":"Zika virus infection in human placental tissue explants is enhanced in the presence of dengue virus antibodies in-vitro","volume":"7","author":"Hermanns","year":"2018","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.coviro.2020.08.006_bib0335","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.aaf8505","article-title":"Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection","volume":"353","author":"Stettler","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.coviro.2020.08.006_bib0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006487","article-title":"Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques","volume":"13","author":"McCracken","year":"2017","journal-title":"PLOS Pathog"},{"key":"10.1016\/j.coviro.2020.08.006_bib0345","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15674","article-title":"Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus","volume":"8","author":"Pantoja","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2020.08.006_bib0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007766","article-title":"Primary infection with dengue or Zika virus does not affect the severity of heterologous secondary infection in macaques","volume":"15","author":"Breitbach","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2020.08.006_bib0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-05458-0","article-title":"Cross-reactive dengue virus-specific CD8+ T cells protect against Zika virus during pregnancy","volume":"9","author":"Regla-Nava","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2020.08.006_bib0360","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01669-z","article-title":"Dengue virus-reactive CD8+ T cells mediate cross-protection against subsequent Zika virus challenge","volume":"8","author":"Wen","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2020.08.006_bib0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107566","article-title":"CD4+ T cells cross-reactive with dengue and Zika viruses protect against Zika virus infection","volume":"31","author":"Wen","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.coviro.2020.08.006_bib0370","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41564-019-0618-z","article-title":"Evolution of the innate and adaptive immune response in women with acute Zika virus infection","volume":"5","author":"Tonnerre","year":"2020","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.coviro.2020.08.006_bib0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107569","article-title":"Comprehensive immunoprofiling of pediatric Zika reveals key role for monocytes in the acute phase and no effect of prior dengue virus infection","volume":"31","author":"Michlmayr","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.coviro.2020.08.006_sbref0380","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz320","article-title":"Prior dengue virus infection is associated with increased viral load in patients infected with dengue but not Zika virus","volume":"6","author":"Santiago","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.coviro.2020.08.006_bib0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002726","article-title":"Prior dengue virus infection and risk of Zika: a pediatric cohort in Nicaragua","volume":"16","author":"Gordon","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.coviro.2020.08.006_bib0390","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1126\/science.aav6618","article-title":"Impact of preexisting dengue immunity on Zika virus emergence in a dengue endemic region","volume":"363","author":"Rodriguez-Barraquer","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.coviro.2020.08.006_bib0395","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/cid\/cix472","article-title":"Maternal Zika virus disease severity, virus load, prior dengue antibodies, and their relationship to birth outcomes","volume":"65","author":"Halai","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2020.08.006_bib0400","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1093\/infdis\/jix539","article-title":"Evidence for congenital Zika virus infection from neutralizing antibody titers in maternal sera, Northeastern Brazil","volume":"216","author":"Moreira-Soto","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2020.08.006_bib0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007246","article-title":"Perinatal analyses of Zika- and dengue virus-specific neutralizing antibodies: a microcephaly case-control study in an area of high dengue endemicity in Brazil","volume":"13","author":"Castanha","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.coviro.2020.08.006_bib0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-58407-7","article-title":"Association of past dengue fever epidemics with the risk of Zika microcephaly at the population level in Brazil","volume":"10","author":"Carvalho","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.coviro.2020.08.006_sbref0415","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-13628-x","article-title":"Impacts of Zika emergence in Latin America on endemic dengue transmission","volume":"10","author":"Borchering","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2020.08.006_bib0420","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aan6809","article-title":"Zika virus activates de novo and cross-reactive memory B cell responses in dengue-experienced donors","volume":"2","author":"Rogers","year":"2017","journal-title":"Sci Immunol"},{"key":"10.1016\/j.coviro.2020.08.006_bib0425","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/v11010019","article-title":"Pre-existing dengue immunity drives a DENV-biased plasmablast response in ZIKV-infected patient","volume":"11","author":"Bhaumik","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.coviro.2020.08.006_bib0430","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/s41467-019-08845-3","article-title":"Impact of pre-existing dengue immunity on human antibody and memory B cell responses to Zika","volume":"10","author":"Andrade","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2020.08.006_bib0435","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005554","article-title":"Dissecting the human serum antibody response to secondary dengue virus infections","volume":"11","author":"Patel","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.coviro.2020.08.006_bib0440","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature20564","article-title":"Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice","volume":"540","author":"Sapparapu","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2020.08.006_bib0445","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-med-040717-051127","article-title":"Zika virus vaccine development: progress in the face of new challenges","volume":"70","author":"Diamond","year":"2019","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.coviro.2020.08.006_sbref0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mBio.01485-19","article-title":"Role of Zika virus envelope protein domain III as a target of human neutralizing antibodies","volume":"10","author":"Gallichotte","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.coviro.2020.08.006_bib0455","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.cell.2017.04.024","article-title":"Recurrent potent human neutralizing antibodies to Zika virus in Brazil and Mexico","volume":"169","author":"Robbiani","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2020.08.006_bib0460","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41591-019-0746-2","article-title":"Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor","volume":"26","author":"Dussupt","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2020.08.006_sbref0465","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133653","article-title":"Reciprocal immune enhancement of dengue and Zika virus infection in human skin","volume":"5","author":"Castanha","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.coviro.2020.08.006_bib0470","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/infdis\/jiw377","article-title":"Zika virus-induced antibody response enhances dengue virus serotype 2 replication in vitro","volume":"214","author":"Kawiecki","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2020.08.006_bib0475","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/infdis\/jiy482","article-title":"Dengue virus and Zika virus serological cross-reactivity and their impact on pathogenesis in mice","volume":"219","author":"Watanabe","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2020.08.006_sbref0480","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.chom.2018.09.015","article-title":"Maternally acquired Zika antibodies enhance dengue disease severity in mice","volume":"24","author":"Fowler","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2020.08.006_bib0485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-10901-1","article-title":"Prior exposure to Zika virus significantly enhances peak dengue-2 viremia in rhesus macaques","volume":"7","author":"George","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.coviro.2020.08.006_bib0490","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-12295-2","article-title":"Time elapsed between Zika and dengue virus infections affects antibody and T cell responses","volume":"10","author":"P\u00e9rez-Guzm\u00e1n","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2020.08.006_bib0495","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41426-018-0132-z","article-title":"Zika convalescent macaques display delayed induction of anamnestic cross-neutralizing antibody responses after dengue infection","volume":"7","author":"Valiant","year":"2018","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.coviro.2020.08.006_bib0500","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.00517","article-title":"Two is better than one: evidence for T-cell cross-protection between dengue and Zika and implications on vaccine design","volume":"11","author":"Subramaniam","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2020.08.006_bib0505","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1146\/annurev-immunol-042617-053142","article-title":"Immune response to dengue and Zika","volume":"36","author":"Elong Ngono","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.coviro.2020.08.006_bib0510","doi-asserted-by":"crossref","first-page":"11383","DOI":"10.1128\/JVI.01108-14","article-title":"Immunodominance changes as a function of the infecting dengue virus serotype and primary versus secondary infection","volume":"88","author":"Weiskopf","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.08.006_bib0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.01469-17","article-title":"Prior dengue virus exposure shapes T cell immunity to Zika virus in humans","volume":"91","author":"Grifoni","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.08.006_bib0520","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.4049\/jimmunol.1801090","article-title":"Cutting edge: transcriptional profiling reveals multifunctional and cytotoxic antiviral responses of Zika virus\u2013specific CD8 + T cells","volume":"201","author":"Grifoni","year":"2018","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2020.08.006_bib0525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.00185","article-title":"Strong CD4 T cell responses to Zika virus antigens in a cohort of dengue virus immune mothers of congenital Zika virus syndrome infants","volume":"11","author":"Reynolds","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2020.08.006_bib0530","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-18781-1","article-title":"T cell immunity to Zika virus targets immunodominant epitopes that show cross-reactivity with other flaviviruses","volume":"8","author":"Reynolds","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.coviro.2020.08.006_bib0535","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nature17994","article-title":"Structure of the thermally stable Zika virus","volume":"533","author":"Kostyuchenko","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2020.08.006_bib0540","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01396-16","article-title":"Zika virus is not uniquely stable at physiological temperatures compared to other flaviviruses","volume":"7","author":"Goo","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.coviro.2020.08.006_bib0545","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006178","article-title":"A single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesis","volume":"13","author":"Goo","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2020.08.006_bib0550","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.20191792","article-title":"Mechanism of differential Zika and dengue virus neutralization by a public antibody lineage targeting the DIII lateral ridge","volume":"217","author":"Zhao","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.coviro.2020.08.006_bib0555","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/infdis\/jix473","article-title":"CD-loop extension in Zika virus envelope protein key for stability and pathogenesis","volume":"216","author":"Gallichotte","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2020.08.006_bib0560","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nsmb.3352","article-title":"Structure of the immature Zika virus at 9 \u00c5 resolution","volume":"24","author":"Prasad","year":"2017","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.coviro.2020.08.006_sbref0565","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.virol.2017.12.032","article-title":"The Zika virus envelope protein glycan loop regulates virion antigenicity","volume":"515","author":"Goo","year":"2018","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2020.08.006_bib0570","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.3390\/cells8111444","article-title":"The envelope residues E152\/156\/158 of Zika virus influence the early stages of virus infection in human cells","volume":"8","author":"Bos","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.coviro.2020.08.006_bib0575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.00113-19","article-title":"Envelope protein glycosylation mediates Zika virus pathogenesis","volume":"93","author":"Carbaugh","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.08.006_bib0580","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00109-008-0350-2","article-title":"DC-SIGN and L-SIGN: the SIGNs for infection","volume":"86","author":"Khoo","year":"2008","journal-title":"J Mol Med"},{"key":"10.1016\/j.coviro.2020.08.006_bib0585","doi-asserted-by":"crossref","first-page":"7136","DOI":"10.1128\/JVI.00116-07","article-title":"Essential role of dengue virus envelope protein N glycosylation at asparagine-67 during viral propagation","volume":"81","author":"Mondotte","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.08.006_bib0590","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.antiviral.2012.10.007","article-title":"Crucial role of the N-glycans on the viral E-envelope glycoprotein in DC-SIGN-mediated dengue virus infection","volume":"96","author":"Alen","year":"2012","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.08.006_bib0595","doi-asserted-by":"crossref","first-page":"37183","DOI":"10.1074\/jbc.M605429200","article-title":"The location of asparagine-linked glycans on West Nile virions controls their interactions with CD209 (dendritic cell-specific ICAM-3 grabbing nonintegrin)","volume":"281","author":"Davis","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coviro.2020.08.006_bib0600","doi-asserted-by":"crossref","first-page":"11800","DOI":"10.1128\/JVI.05237-11","article-title":"A fusion-loop antibody enhances the infectious properties of immature flavivirus particles","volume":"85","author":"Rodenhuis-Zybert","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.08.006_sbref0605","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1073\/pnas.1812055115","article-title":"Dengue type 1 viruses circulating in humans are highly infectious and poorly neutralized by human antibodies","volume":"116","author":"Raut","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2020.08.006_bib0610","doi-asserted-by":"crossref","first-page":"10776","DOI":"10.1128\/JVI.01180-08","article-title":"Differential modulation of prM cleavage, extracellular particle distribution, and virus infectivity by conserved residues at nonfurin consensus positions of the dengue virus pr-M junction","volume":"82","author":"Junjhon","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.08.006_bib0615","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1800820","article-title":"Effect of dengue serostatus on dengue vaccine safety and efficacy","volume":"379","author":"Sridhar","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2020.08.006_bib0620","series-title":"Weekly Epidemiological Record 7th September 2018","first-page":"457","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.coviro.2020.08.006_bib0625","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1056\/NEJMoa1903869","article-title":"Efficacy of a tetravalent dengue vaccine in healthy children and adolescents","volume":"381","author":"Biswal","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2020.08.006_sbref0630","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw9066","article-title":"Distinct neutralizing antibody correlates of protection among related Zika virus vaccines identify a role for antibody quality","volume":"12","author":"Maciejewski","year":"2020","journal-title":"Sci Transl Med"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625720300730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625720300730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:04:07Z","timestamp":1761818647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625720300730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":126,"alternative-id":["S1879625720300730"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2020.08.006","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective and enhancing interactions among dengue viruses 1-4 and Zika virus","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2020.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}